Key Considerations When Selecting A CDMO Partner For Cell Therapy Manufacturing

The cell and gene therapy market is experiencing accelerated market approvals, record breaking investments, robust therapeutic pipelines, and positive clinical outcomes – all driving the need for speed, regulatory know-how, and innovation in manufacturing technologies.

Selecting the right CDMO partner is key to navigating industry challenges and realizing opportunities to get your product to market faster. This webinar shares key considerations when selecting a CDMO partner to support your cell therapy manufacturing strategy.

Key learning objectives:

• Key assessment criteria when evaluating potential CDMO partners
• Benefits of an integrated services approach to streamline the path to commercialization and address industry challenges
• Insights from current Thermo Fisher cell therapy manufacturing partner on managing CDMO relationships
• Overview of Thermo Fisher experience, capacity, and integrated development and manufacturing services